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free physical activity: a community-based
proof-of-concept trial
Trentham Furness1,2,3*, Corey Joseph4, Liam Welsh5, Geraldine Naughton2 and Christian Lorenzen2Abstract
Background: The potential of whole-body vibration (WBV) as a mode of dyspnoea free physical activity for people
with chronic obstructive pulmonary disease (COPD) is unknown among community-based settings. Furthermore,
the acute effects of WBV on people with COPD have not been profiled in community-based settings. The aim of
this community-based proof-of-concept trial was to describe acute effects of WBV by profiling subjective and
objective responses to physical activity.
Findings: Seventeen community-dwelling older adults with COPD were recruited to participate in two sessions; WBV
and sham WBV (SWBV). Each session consisted of five one-minute bouts interspersed with five one-minute passive rest
periods. The gravitational force was ~2.5 g for WBV and ~0.0 g for SWBV. Reliability of baseline dyspnoea, heart rate,
and oxygen saturation was first established and then profiled for both sessions. Acute responses to both WBV and
SWBV were compared with repeated measures analysis of variance and repeated contrasts. Small changes in dyspnoea
and oxygen saturation lacked subjective and clinical meaningfulness. One session of WBV and SWBV significantly
increased heart rate (p≤ 0.02), although there was no difference among WBV and SWBV (p = 0.67).
Conclusions: This community-based proof-of-concept trial showed that a session of WBV can be completed with the
absence of dyspnoea for people with COPD. Furthermore, there were no meaningful differences among WBV and
SWBV for heart rate and oxygen saturation. There is scope for long-term community-based intervention research using
WBV given the known effects of WBV on peripheral muscle function and functional independence.
Keywords: Dyspnoea, Whole-body vibration, Heart rate, Acute responsesFindings
Background
A disease of the lungs, chronic obstructive pulmonary dis-
ease (COPD) is a leading cause of mortality worldwide
[1]. Data of the Australian Bureau of Statistics report
COPD to be more common than most cancers, road traf-
fic accidents, coronary artery disease, and diabetes [2]. An
estimated 2.1 million Australians are affected by COPD,
with an estimated increase to 4.5 million by 2050 [2].
Considering the known effect of COPD on mortality and
a predicted increase of incidence of COPD, research about* Correspondence: trentham.furness@acu.edu.au
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stated.assessment, prevention, management, and treatment of
the disease is salient.
Peripheral muscle training is an important component
of pulmonary rehabilitation for the management of
COPD [3]. Position statements from respiratory bodies
including the GOLD, the American Thoracic Society
and the European Respiratory Society support the use of
resistance training and aerobic conditioning as modes of
physical activity to improve peripheral muscle function
of people with COPD. The risk of acute dyspnoea or
hypoxemia during resistance training [4,5] and or aer-
obic conditioning [6-8] is secondary to the known risks
associated with physical inactivity. An ongoing challenge
of peripheral muscle training therefore, remains to de-
sign physical activity interventions that stimulate the
cardiovascular and musculoskeletal systems to allow
physiological adaptations yet maximise compliance [9].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Descriptors of the participants with COPD
Descriptor Pre Post
Mean SD 95% CI Mean SD 95% CI
FEV1 (L BTPS) 1.4 0.5 ± 1.0 1.6 0.6 ± 1.2
FEV1 % predicted 52.1 17.5 ± 34.3 58.2 19.4 ± 38.0
FVC (L BTPS) 2.8 0.8 ± 1.6 3.1 0.8 ± 1.6
FVC % predicted 80.3 16.1 ± 31.6 84.5 17.3 ± 33.9
FER % 52.0 13.7 ± 26.9 52.7 11.8 ± 23.1
PEF (L.sec-1) 3.8 1.4 ± 2.7 4.2 0.9 ± 1.8
Age (years) 69 8
Stature (m) 1.7 0.9
Mass (kg) 83.9 19.2
BMI (kg.m-2) 24.7 5.1
SBP (mmHg) 136 15
DBP (mmHg) 73 11
BMI: body mass index. SBP: systolic blood pressure. DBP: diastolic
blood pressure.
Furness et al. BMC Research Notes 2013, 6:452 Page 2 of 4
http://www.biomedcentral.com/1756-0500/6/452Whole-body vibration (WBV) is a mode of physical ac-
tivity known to strengthen the peripheral muscles of the
lower limbs [10,11]. A growing body of literature on the
effects of WBV within sub-optimal health populations
exists, yet studies of effects of WBV on people with
COPD are limited in number and confined to the hos-
pital/laboratory. Despite the potential benefits of WBV
to strengthen peripheral muscles of the lower limbs
when incorporated with pulmonary rehabilitation, the
acute responses of people with COPD to WBV have not
been profiled in community-based settings. As such, this
proof-of-concept trial was conducted to determine if
WBV could be a mode of dyspnoea free physical activity
and was the first stage of community-based Phase II effi-
cacy trial [12]. The aim of this trial was to profile acute
subjective and objective responses of people with COPD
to a single session of WBV and a single session of sham
WBV (SWBV). If as a concept, WBV could be completed
with the absence of dyspnoea, compliance to a long-term
community-based WBV intervention may be enhanced
among people with COPD. As such, it was hypothesisedTable 2 Effects of WBV and SWBV on subjective and objective
WBV
Dependent variable Mean (SD) 95% Confidence (SE)
eLower Upper
Borg CR-10 baseline 1 (2) 0 2
Borg CR-10 during bout 2 (2) 1 3
HR baseline (beats.min-1) 81 (12) 75 87
HR during bout (beats.min-1) 92 (13) 85 99
SpO2 baseline (%) 97 (2) 96 97
SpO2 during bout (%) 96 (2) 95 97
*; p ≤ 0.02.there would be no difference of perceived dyspnoea, heart
rate, and oxygen saturation among WBV and SWBV.
Methods
Seventeen adults with COPD provided informed voluntary
consent to participate in the trial. The trial was approved by
the Southern Health Human Research Ethics Committee A.
The trial was registered with the Australian New Zealand
Clinical Trials Registry (ANZCTR12612000508875). Partici-
pants were recruited from Metropolitan Melbourne and
the Mornington Peninsula, Victoria, Australia. Data were
collected in the home of each participant by TF.
Participants were community-dwelling and functionally
independent. Spirometry data were collected as part of
usual care at the Monash Medical Centre with the
methods described by American Thoracic Society and the
European Respiratory Society and GOLD classifications.
The subjective dependent variable of perceived dys-
pnoea was quantified with the Borg category-ratio CR-
10 (Borg CR-10) [13] visual analogue scale. The objective
dependent variables were heart rate and oxygen satur-
ation (SpO2), quantified using the CARESCOPE™ V100
Vital Sign Monitor (GE Health Care, Milwaukee, USA).
Reliability of the dependent variables was established
prior to the WBV and SWBV sessions across a standard
test-retest-retest protocol [14] in the home of each par-
ticipant. Intraclass correlation coefficients were classified
as ‘acceptable’ (ICC ≥ 0.700) for all dependent variables.
Participants first completed a single session of WBV,
then a single session of SWBV at least seven days later. In
accordance with our trial protocol [12], this proof-of-
concept trial was completed as a non-randomised inter-
vention with crossover to sham. A side alternating vibra-
tion platform (Amazing Super Health, Melbourne,
AUS) was used. For the single WBV session, platform
frequency was ~25 Hz and peak-to-peak displacement
was ~2.0 mm, peak acceleration was ~24.7 m.s-2, gravi-
tational force was ~2.5 g. For the single SWBV session,
platform frequency was ~25 Hz and peak-to-peak dis-
placement was ~0.0 mm. Foot placement (second toe)
was equidistant, 20 cm from the axis of rotation forvariables
SWBV
Sig. (Partial
ta squared)
Mean (SD) 95% Confidence (SE) Sig. (Partial
eta squared)Lower Upper
0.01* 1 (1) 1 2 0.08
(0.50) 2 (1) 1 3 (0.36)
0.01* 85 (12) 79 91 0.01*
(0.88) 93 (14) 86 100 (0.70)
0.08 95 (2) 95 96 0.61
(0.18) 95 (2) 95 97 (0.02)
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shoes and stood with ~20° knee flexion when checked
with a manual goniometer during each session. The sin-
gle WBV and SWBV sessions consisted of five, one-
minute vibration bouts, interspersed with one-minute
of passive rest. Although the most effective test protocol
is yet to be established, the selected test protocol had
been used previously to describe acute effects of WBV
among other populations [15-17]. During rest, the
participant remained on the vibration platform, but
was encouraged to stand with a posture that mimicked
the ‘anatomical position’ (International Society for the
Advancement of Kinanthropometry). Skidding was checked
to confirm the vibration platform gravitational forces with
the methods of the International Society of Musculoskeletal
and Neuronal Interactions [18].
Data were collected at baseline (after the participant had
been sitting quietly in a chair for five minutes) and within
30 seconds of the completion of the final WBV or SWBV
bout. After normality, repeated measures analysis of vari-
ance with repeated contrasts were computed for differences
between rest and during a bout (n = 17) with SPSS (Version
19, Chicago, IL). Effect size was reported as Partial eta
squared (Partial η2). To minimise the potential for family-
wise error rate, significance was accepted at p ≤ 0.02.
Results
With GOLD classification, 14 participants were affected
by moderate Stage II COPD and three participants by
severe Stage III COPD (Table 1). Changes in perceived
dyspnoea remained stable from ‘very slight’ to ‘slight’
among WBV and SWBV (Table 2). Both single sessions
increased heart rate (p = 0.01). The increase in heart rate
was more with WBV (11 beats.min-1, Partial η2 = 0.88)
than with SWBV (8 beats.min-1, Partial η2 = 0.70). The
difference among heart rate increases was not significant
(p = 0.67). Oxygen saturation reduced by 1% during WBV
(p = 0.08) and did not change during SWBV (p = 0.61).
Discussion
Findings of this community-based proof-of-concept trial
support the use of WBV as a mode of dyspnoea free
physical activity for people with COPD. Furthermore,
there were no meaningful differences among WBV and
SWBV for acute subjective and objective variables.
The results show WBV does not elicit a physical de-
mand comparable with resistance training and aerobic
conditioning for people with COPD. People with stage II
COPD perceived dyspnoea (Borg CR-10) less during
WBV compared with resistance training [4], treadmill
walking [19], and the six-minute walk test [20]. Heart
rate during WBV in this community-based trial was
lower compared with combined resistance training and
aerobic conditioning [4] and fast paced exercise [7]. Inthis community-based trial, oxygen saturation reduced
from 97 to 96% during WBV, yet the clinical meaningful-
ness was negligible due to an absence of hypoxemia des-
pite the moderate effect size (Partial η2 = 0.18) (Table 2).
Safety recommendations are that exercise should be
terminated if oxygen saturation reduces to ≤ 85% [21,22].
The WBV gravitational force of the vibration platform
in this community-based trial was ~2.5 g. For non-
community dwelling older adults, heart rate increased to
135 beats.min-1 when the gravitational force was 9.5 g
[17]. Exposure to WBV at 8.0 g in healthy adults elevated
heart rate reserve by 8% [23]. However, the potential for
higher heart rates with increased gravitational forces
during WBV should be offset with the risk of bone dam-
age [24]. Subsequently, the appropriateness of prescribed
doses of WBV should be at the forefront of exercise
intervention planning for people with COPD.
The results of this community-based proof-of-concept
trial support the use of WBV as a mode of dyspnoea free
physical activity for people with COPD. However, not
every prescribed load and protocol will be appropriate
and dyspnoea responses may vary depending on desensi-
tisation. Further study of WBV among clinical setting
may describe acute effects on dyspnoea in patients with
‘severe’ COPD. Among community-based settings, fur-
ther study of effects of WBV on peripheral muscle func-
tion of the lower limbs should be conducted to establish
efficacy of WBV as a strengthening tool because the re-
sults of this trial support the use of WBV as a dyspnoea
free mode of physical activity for people with COPD.
Conclusions
Using dose appropriate prescription, WBV was a mode of
dyspnoea free physical activity for people with COPD
in this community-based proof-of-concept trial. Acute
changes in subjective and objective responses to physical
activity during WBV were clinically meaningless. The po-
tential of long-term community-based WBV interventions
to improve function of the peripheral muscles of the lower
limbs remains unknown yet should be described because
WBV did not change perceived breathlessness of people
with COPD.
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